Evidence map›Paper›PMID 39910336›Full record

ArticleCellular & molecular immunology2025

GLP1 alleviates oleic acid-propelled lipocalin-2 generation by tumor-infiltrating CD8

Jingyi Wu, Peng Qian, Yifeng Han, Chuning Xu, Mao Xia, Ping Zhan, Jiwu Wei, Jie Dong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular & molecular immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. NF-κB in inflammation and cancer.Cellular & molecular immunology · 2025
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jingyi Wu *State Key Laboratory of Pharmaceutical Biotechnology and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Peng Qian *State Key Laboratory of Pharmaceutical Biotechnology and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Yifeng Han *State Key Laboratory of Pharmaceutical Biotechnology and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Chuning XuState Key Laboratory of Pharmaceutical Biotechnology and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Mao XiaDepartment of Clinical Laboratory Medicine, the Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Ping ZhanDepartment of Respiratory Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Jiwu WeiState Key Laboratory of Pharmaceutical Biotechnology and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China. wjw@nju.edu.cn.
Jie DongState Key Laboratory of Pharmaceutical Biotechnology and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China. dongjie@nju.edu.cn.

Funding

Nanjing University (NJU) 0214/151130National Natural Science Foundation of China (National Science Foundation of China) 82073367National Natural Science Foundation of China (National Science Foundation of China) 82273261State Key Laboratory of Pharmaceutical Biotechnology (SKL of Pharmaceutical Biotechnology, Nanjing University) ZZYJ-202401
6 · The paper itself

Abstract

Recruitment of polymorphonuclear MDSCs (PMN-MDSCs) in the TME suppresses the antitumor activity of tumor-infiltrating CD8

Indexed as

CD8-Positive T-LymphocytesImmunotherapyLipocalin-2Lymphocytes, Tumor-InfiltratingMyeloid-Derived Suppressor CellsOleic AcidPancreatic NeoplasmsAnimalsCell Line, TumorFemaleHumansMiceMice, Inbred C57BLTumor MicroenvironmentLipocalin-2Oleic Acidfatty acidglucagon-like peptide 1lipocalin 2PMN-MDSCsTumor immunotherapy

Identifiers

PMID39910336
PMCPMC11868399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.